UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.

UEG Week Berlin 2025 Recordings Gut Guide online

Rate for better recommendations!

Your feedback helps us show you more of what you like and less of what you dislike!

More of this!

We will show you more similar content.

Not for me!

We won't suggest this again.

Bookmark!

Save this content for later!

New to myUEG? Create an account! Log In with myUEG account

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.

Not sure what you can access? Learn more about account types.

Introduction

The adherence of doctors and patients to published colorectal post-polypectomy surveillance guidelines varies greatly, and patient follow-up is critical but time-consuming.

Aims & Methods

Aims: We aimed to develop an automatic surveillance (AS) system to accurately identify post-polypectomy patients, assign surveillance intervals for different risks of patients and proactively follow up with patients on time.
Methods: The endoscopic and pathological reports from 47,544 patients from three hospitals were used to develop AS system based on natural language processing. The performance of AS system was fully evaluated in internal and external tests according to five different guidelines worldwide and compared with that of doctors. Furthermore, a multi-reader-multi-case (MRMC) trial was conducted to evaluate the effect of AS system on improving doctors’ guideline adherence and efficiency, and a prospective trial was performed to evaluate the success rate for automatically informing patients and its effect on reducing the burden of nurses.

Results

In internal, external 1, and external 2 tests, the system reached an overall accuracy of 99.73%, 99.54%, and 99.77% for identifying different types of patients, respectively; and achieved an overall accuracy of ≥99.45%, ≥98.89%, and ≥98.56% for stratifying patients' risk levels and assigning surveillance intervals according to five guidelines. The system greatly increased the accuracy of doctors (98.67% vs. 78.10%, p=0.043) in MRMC trial. In a prospective trial, AS system successfully informed 93·18% of patients, and significantly reduced the follow-up time cost (127.4s vs. 14.02s per patient).

Conclusion

This system has great potential to improve doctors' adherence to guidelines while relieving the workload of doctors and nurses.

Disclosure

The authors declare no conflict of interest.

THE DEVELOPMENT AND CLINICAL EVALUATION OF A NATURAL LANGUAGE PROCESSING-BASED AUTOMATIC SURVEILLANCE SYSTEM FOR COLORECTAL POST-POLYPECTOMY PATIENTS

CONGHUI SHI 1, Lianlian Wu 1, Jia Li 1, Honggang Yu 1

1 Renmin Hospital of Wuhan University, Wuhan, China

Conference

UEG Week Copenhagen 2023

Topics

Colorectal

Submission format

Abstract

Session

PP 06 Other lower GI disorders (Posters)

Citation

United European Gastroenterology Journal 2023; 11 (Supplement 8)

Published

2023

UEG Standards and Guidelines

Position Paper

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

Abstract

Objectives

Jejunal tube feeding (JTF) is increasingly becoming the standard of care for children in whom gastric tube feeding is insufficient to achieve caloric needs. Given a lack of a systematic approach to the care of JTF in paediatric patients, the aim of this position paper is to provide expert guidance regarding the indications for its use and practical considerations to optimize its utility and safety.

Methods

A group of members of the Gastroenterology and Nutrition Committees of the European Society of Paediatric Gastroenterology Hepatology and Nutrition and of invited experts in the field was formed in September 2016 to produce this clinical guide. Seventeen clinical questions treating indications and contraindications, investigations before placement, techniques of placement, suitable feeds and feeding regimen, weaning from JTF, complications, long-term care, and ethical considerations were addressed.

A systematic literature search was performed from 1982 to November 2018 using PubMed, the MEDLINE, and Cochrane Database of Systematic Reviews. Grading of Recommendations, Assessment, Development, and Evaluation was applied to evaluate the outcomes.

During a consensus meeting, all recommendations were discussed and finalized. In the absence of evidence from randomized controlled trials, recommendations reflect the expert opinion of the authors.

Results

A total of 33 recommendations were voted on using the nominal voting technique.

Conclusions

JTF is a safe and effective means of enteral feeding when gastric feeding is insufficient to meet caloric needs or is not possible. The decision to place a jejunal tube has to be made by close cooperation of a multidisciplinary team providing active follow-up and care.

The Use of Jejunal Tube Feeding in Children

Ilse Broekaert

Publisher

European Society for Paediatric Gastroenterology, Hepatology and Nutrition

Guideline

Position Paper

Topics

Paediatrics Small Intestine & Nutrition

Citation

Journal of Pediatric Gastroenterology and Nutrition, 69: 239-258

Published

2019

UEG Standards and Guidelines

Position Paper

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

Abstract

Objectives

Videofluoroscopic swallowing studies (VFSS) remain the gold standard for the instrumental assessment of oropharyngeal swallowing disorders alongside flexible endoscopic evaluation of swallowing (FEES), requiring a high standard of quality and correct implementation. The current best practice position statements aim to guide the clinical practice of VFSS in individuals experiencing swallowing disorders.

Materials and methods

An international expert consensus panel with expertise in oropharyngeal dysphagia, comprised of radiologists, speech-language therapists, otolaryngologists, and other professionals in the field, convened by the European Society of Swallowing Disorders (ESSD) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), developed best practice position statements. They were established using an online Delphi methodology involving an online panel discussion and item preparation and three consecutive rounds. Consensus was reached when ≥ 80% of the participants agreed on a specific recommendation.

Results

Eighteen best practice position statements were formulated, thereby establishing standard recommendations on the technical performance of VFSS. They cover VFSS planning, correct implementation, documentation, radiation protection, equipment and maintenance, and education and training.

Conclusion

These position statements summarise the panel’s deliberations and recommendations in performing VFSS, representing the agreed consensus of experts from ESSD and ESGAR. They provide a structured framework for optimising and standardising the performance of VFSS in patients with swallowing disorders.

Key Points

Question Significant regional and national differences in clinical practice when performing VFSS highlight the need for interdisciplinary recommendations to optimise patient care.

Findings Eighteen statements were developed by representatives of the ESSD and the ESGAR.

Clinical relevance These best practice position statements on the technical performance of VFSS may serve as a basis for standardising the procedure and ensuring high-quality service.

ESSD–ESGAR best practice position statements on the technical performance of videofluoroscopic swallowing studies in adult patients with swallowing disorders

Martina Scharitzer

Publisher

European Society of Gastrointestinal and Abdominal Radiology

Guideline

Position Paper

Topics

Radiology & Imaging

Citation

Eur Radiol 35, 3169–3180 (2025)

Published

2024

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

Established and novel targets for breath testing

Christian Schulz 1

1 Ludwig Maximilian University, Munich, Germany

Event

UEG Week Berlin 2025

Topics

Mechanisms & Personalised Medicine

Session

Breath testing and clinical metabolomics: Back to the future

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

When to think about gastroparesis and what to do

Jan Martinek 1

1 Institute for Clinical and Experimental Medicine Gastroenterology & Hepatology, Praha, Czech Republic

Event

UEG Week Berlin 2025

Topics

Neurogastroenterology & Motility Primary Care

Session

Therapy update: Dyspepsia

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

UEG Presentation

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

GP: First line diagnosis and treatment

Juan Mendive 1

1 European Society for Primary Care Gastroenterology (ESPCG), Sant Adrià de Besòs ( Barcelona), Spain

Event

UEG Week Berlin 2025

Topics

Neurogastroenterology & Motility Primary Care

Session

Therapy update: Dyspepsia

Citation

United European Gastroenterology Journal 2025; 13 (Supplement 8)

Published

2025

UEG Poster

Standard Poster

Share via Email Share on Facebook Share on X Share on LinkedIn Share on Bluesky

Not sure what you can access? Learn more about account types.

Introduction

Barrett’s oeosphagus (BO) is the precursor to oesophageal adenocarcinoma (OAC), a malignancy with a poor overall prognosis. Endoscopic surveillance of patients with BO aims to detect dysplasia and OAC to improve long-term outcomes. However, the majority of patients with BO do not progress to cancer.^1,2 It is therefore important to establish the relevant clinical risk factors for malignant progression in this cohort to enable risk stratification and facilitate a personalised approach to management. While obesity is an independent risk factor for both BO and OAC,^3-5 the role of obesity in the malignant progression of BO is unclear. We undertook a systematic review and dose-response meta-analysis to estimate the association between obesity and malignant progression in patients with BO.

Aims & Methods

We searched MEDLINE and EMBASE databases via the OVID interface to December 2023. Studies which reported the effect of body mass index (BMI) on the progression of BO (no dysplasia or low-grade dysplasia[LGD] at baseline) to HGD or OAC were included. Two-stage dose-response meta-analysis was performed to estimate the association between BMI and malignant progression. Study quality was appraised using a modified Newcastle-Ottawa scale. The review was registered on PROSPERO (CRD42017051046).

Results

Twenty studies reported data on 38565 patients in total, of whom 1684 patients were diagnosed with HGD/OAC/OC. Each 5kg/m²increase in BMI was associated with a 4% increase in malignant progression to HGD or OAC (unadjusted OR 1.04; 95% CI 1.00 to 1.07; p<0.001; I² 57.2%). The association remained consistent after adjusting for potential confounders (adjusted OR 1.06; 95% CI 1.02 to 1.10;p<0.001; I² 0%). Nineteen studies were considered moderate to high quality.

Conclusion

Our meta-analysis suggests that obesity as measured by BMI is associated with malignant progression of BO with a dose-response relationship. The findings from our study are consistent with mechanistic evidence for the role of obesity in the pathogenesis of OAC. Future risk prediction models could incorporate measures of obesity to potentially improve risk stratification in patients with BO. Weight loss might reduce the risk of malignant progression in patients with BO.

References

1. Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst 2011;103:1049-57.
2. Hvid-Jensen F, Pedersen L, Drewes AM, et al. Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med 2011;365:1375-83.
3. Kubo A, Cook MB, Shaheen NJ, et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut 2013;62:1684-91.
4. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008;371:569-78.
5. Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev 2008;17:352-8